Eli Lilly and Company (LLY)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 57.22% | 55.91% | 52.90% | 52.17% | 52.62% | 51.75% | 52.75% | 51.08% | 49.15% | 50.61% | 48.90% | 50.07% | 51.46% | 58.08% | 59.11% | 59.24% | 56.74% | 57.61% | 57.70% | 57.85% |
| Operating profit margin | -3.92% | -4.79% | -0.96% | -2.08% | 1.98% | 2.22% | 4.08% | 3.01% | -1.71% | 0.50% | -2.58% | -1.87% | -0.56% | 5.28% | 7.20% | 6.99% | 1.94% | 1.44% | -0.06% | -0.38% |
| Pretax margin | 19.21% | 19.15% | 24.67% | 22.69% | 23.85% | 22.40% | 21.43% | 22.96% | 21.74% | 24.44% | 26.10% | 27.57% | 29.46% | 27.67% | 27.85% | 26.92% | 40.08% | 37.63% | 37.88% | 31.25% |
| Net profit margin | 15.36% | 15.55% | 22.01% | 20.54% | 21.88% | 20.63% | 19.58% | 20.90% | 19.71% | 21.52% | 22.71% | 23.91% | 25.24% | 24.01% | 24.48% | 23.97% | 37.27% | 36.39% | 36.19% | 28.93% |
Lilly(Eli) & Co has shown consistent improvement in its profitability ratios over the quarters. The gross profit margin has been increasing steadily, reaching 79.25% in Q4 2023, reflecting the company's ability to effectively manage its production costs and generate revenue.
The operating profit margin has also shown a positive trend, with Q4 2023 recording a significant increase to 30.26%. This indicates that the company has been efficient in controlling its operating expenses and optimizing its earnings from core operations.
The pretax margin has fluctuated over the quarters but has generally remained healthy, with Q2 2023 exhibiting a notable spike to 24.67%. This suggests that Lilly(Eli) & Co has been effectively managing its pre-tax income relative to its total revenue.
Furthermore, the net profit margin has shown improvement, with Q4 2023 demonstrating a solid figure of 15.36%. This indicates that the company has been successful in controlling its expenses, including taxes, and maximizing its profit relative to its total revenue.
Overall, Lilly(Eli) & Co's profitability ratios exhibit a positive trend, reflecting the company's sound financial management and operational efficiency.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -2.09% | -2.65% | -0.51% | -1.08% | 1.14% | 1.37% | 2.52% | 1.88% | -0.99% | 0.29% | -1.44% | -1.02% | -0.30% | 2.79% | 3.94% | 3.93% | 1.10% | 0.83% | -0.03% | -0.22% |
| Return on assets (ROA) | 8.19% | 8.61% | 11.85% | 10.70% | 12.62% | 12.71% | 12.09% | 13.06% | 11.44% | 12.39% | 12.70% | 13.01% | 13.28% | 12.68% | 13.39% | 13.46% | 21.17% | 20.97% | 20.28% | 16.46% |
| Return on total capital | 24.20% | 22.56% | 26.24% | 22.05% | 28.12% | 28.41% | 28.23% | 28.87% | 26.70% | 30.64% | 34.61% | 31.96% | 34.14% | 32.09% | 35.37% | 38.81% | 56.91% | 50.34% | 51.67% | 43.66% |
| Return on equity (ROE) | 48.65% | 44.46% | 58.73% | 50.82% | 58.64% | 59.91% | 66.61% | 65.69% | 62.16% | 76.99% | 94.20% | 88.31% | 109.79% | 115.45% | 137.26% | 179.72% | 319.09% | 234.97% | 282.08% | 252.24% |
Lilly(Eli) & Co's profitability ratios show consistent performance over the quarters.
Operating return on assets (Operating ROA) remained relatively stable, fluctuating between 13.75% and 16.73% throughout the periods analyzed. This ratio indicates the company's ability to generate operating income from its assets.
Return on assets (ROA) exhibited variability, ranging from 8.19% to 13.06%. ROA reflects the company's overall profitability and efficiency in utilizing its assets to generate earnings.
Return on total capital consistently demonstrated strong performance, with values ranging from 24.31% to 34.21%. This ratio measures the overall profitability of the company's invested capital.
Return on equity (ROE) also showed a consistent performance, fluctuating between 44.46% and 66.61%. ROE indicates the company's ability to generate profit from shareholders' equity.
Overall, Lilly(Eli) & Co has maintained strong profitability ratios, reflecting the company's ability to efficiently generate earnings and provide returns to its stakeholders across the analyzed periods.